← Open Payments lookup

SARAH CARTER: Open Payments

NPI 1528532603 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$796 in 41 payments from 12 companies in 2025. Trend: 2023 $1,239 · 2024 $863 · 2025 $796

Food & beverage: $796
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$181
E.R. Squibb & Sons, L.L.C.8$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$113
Alkermes, Inc.2$66
Janssen Pharmaceuticals, Inc3$61
Almatica Pharma LLC2$50
ABBVIE INC.3$46
Luye Pharma (USA) Ltd.2$39
Neurocrine BioSciences, Inc.1$33
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: REXULTI, COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, LOREEV XR, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across CA — which companies pay providers there.